MedTrace Logo

Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces

NCT07066813 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-03-18

No results posted yet for this study

Summary

The goal of this observational study is to determine the most accurate tumor size measurement method for T-staging and prognostic assessment in lung cancer with cystic airspaces (LCCA). The main questions it aims to answer are:

* What is the optimal T-staging approach for accurately classifying lung cancer with cystic airspaces （LCCA) and predicting patient outcomes?
* How do imaging features of cystic lesions correlate with their pathological characteristics?
* What is the relationship between imaging features of cystic airspace-associated lesions and patient prognosis?
* Can optimizing the T-staging method improve clinical decision-making in patients with LCCA?

Conditions

  • Lung Cancer Associated With Cystic Airspaces

Sponsors & Collaborators

  • Central South University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-05-31
Completion
2026-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07066813 on ClinicalTrials.gov